Dark

Check out our API

EDAP
EDAP TMS SA
stock NASDAQ

Inactive

May 29, 2026

4.32USD+2.857%(+0.12)55,885

Pre-market

0.00USD-100.000%(-4.20)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 13, 2022

11:47AM EST EDAP Highlights Publication Of Pre-Clinical Results Using Intraoperative High-Intensity Focused Ultrasound Ablation Of Pancreas In Journal Cancers Benzinga

08:00AM EST Represents first step towards a potential clinical treatment of locally advancedpancreatic cancer GlobeNewswire Inc

Jan 5, 2022

08:00AM EST Company announces several key U.S. Focal Oneinstallations during Q4 GlobeNewswire Inc

Nov 29, 2021

09:30AM EST LYON, France, November 29, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the Company), the global leader in robotic energy-based therapies, today announced that the company will participate in a fireside chat and host investor 1x1 meetings at the Piper Sandler 33rd Annual Virtual Healthcare Conference, which is being held November 29 - December 2. GlobeNewswire Inc

Nov 19, 2021

07:02AM EST HC Wainwright & Co. Maintains Buy on Edap TMS, Lowers Price Target to $11 Benzinga

Nov 18, 2021

07:55AM EST The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings Benzinga

Nov 17, 2021

04:37PM EST Edap TMS Q3 (0.03) vs (0.03) Benzinga

04:35PM EST EDAP Reports Third Quarter 2021 Results and Provides Operational GlobeNewswire Inc

07:53AM EST The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment Benzinga

03:59AM EST Earnings Scheduled For November 17, 2021 Benzinga

Nov 15, 2021

10:37AM EST The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More Benzinga

Nov 10, 2021

08:00AM EST Company to host conference call and webcast on Thursday, November 18, at 8:30 am ET GlobeNewswire Inc

Sep 28, 2021

08:00AM EDT Brings advanced focal ablationto prostate cancer patients in the Pacific Northwest GlobeNewswire Inc

Sep 14, 2021

08:03AM EDT EDAP Announces Presentation of Multiple Abstracts Comparing HIFU To Surgery At American Urological Association 2021 Annual Meeting Benzinga

08:00AM EDT Data demonstrate superiority of HIFU versusradical prostatectomy among prostate cancer patients GlobeNewswire Inc

Sep 7, 2021

04:35PM EDT LYON, France, September 7, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the Company), a global leader in robotic energy-based therapies, today announced that management will present at the following investor conferences during the month of September 2021: GlobeNewswire Inc

Aug 25, 2021

04:36PM EDT Edap TMS Q2 EPS $0.01 Up From $(0.01) YoY, Sales $12.40M Beat $10.30M Estimate Benzinga

04:35PM EDT EDAP Reports Second Quarter 2021 Results and Provides Operational GlobeNewswire Inc

04:03AM EDT Earnings Scheduled For August 25, 2021 Benzinga

Aug 4, 2021

08:51AM EDT EDAP Earlier Issued Prelim. Q2 Guidance; Sees Pre.im. Sales $12.4M vs $13.25M Est. Benzinga

08:48AM EDT Edap TMS Sees Q2 2021 Revs 10.4M Benzinga

08:00AM EDT EDAP Announces Select Preliminary Unaudited Second Quarter 2021 GlobeNewswire Inc

Jul 20, 2021

08:07AM EDT EDAP Issues Letter To Shareholders (Full Letter) Benzinga

08:00AM EDT Successful financing and hiring of MedTech industry veteran Ryan Rhodes to drive accelerated U.S. expansion efforts GlobeNewswire Inc

Jun 15, 2021

08:00AM EDT -- Appointment brings highly experienced medical technology and commercialization leader to drive EDAPs US expansion focus. -- Career accomplishments include 14 years at Intuitive Surgical, where he played a leading role in global clinical expansion of robotic surgery in multiple specialties including urology. GlobeNewswire Inc

May 11, 2021

04:57PM EDT Recap: Edap TMS Q1 Earnings Benzinga

04:48PM EDT Edap TMS Q1 EPS $0.03 Beats $(0.01) Estimate, Sales $12.35M Miss $12.68M Estimate Benzinga

04:30PM EDT EDAP Reports First Quarter 2021 Results and Provides Operational GlobeNewswire Inc

12:47PM EDT Earnings Scheduled For May 11, 2021 Benzinga

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

04:14AM EDT Earnings Scheduled For May 11, 2021 Benzinga

May 4, 2021

08:00AM EDT Company to host conference call and webcast on Wednesday, May12 at 8:30 am EDT GlobeNewswire Inc

Apr 28, 2021

10:01AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2021 Benzinga

06:07AM EDT Piper Sandler Initiates Coverage On Edap TMS with Overweight Rating, Announces Price Target of $13 Benzinga

Apr 23, 2021

02:32PM EDT Mid-Afternoon Market Update: Nasdaq Surges 1.5%; EDAP Shares Plunge Benzinga

12:15PM EDT Mid-Day Market Update: Skechers Jumps On Earnings Beat; Inovio Pharmaceuticals Shares Drop Benzinga

10:22AM EDT Mid-Morning Market Update: Markets Rise; Honeywell Beats Q1 Estimates Benzinga

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

06:43AM EDT EDAP Shares Drop After $28M Equity Raise At 20% Discount; Sees Q1 Sales Between 10M-10.4M Benzinga

02:30AM EDT EDAP Announces Pricing of Follow-On Offering GlobeNewswire Inc

Apr 22, 2021

04:04PM EDT EDAP Announces Launch of Follow-On Offering; Co. Sees Q1 Sales 10M-10.4M Benzinga

04:01PM EDT LYON, France, April 22, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the Company), a global leader in robotic energy-based therapies, announced today the launch of a follow-on public offering of its American Depositary Shares, or ADSs, each representing one ordinary share of the Company. GlobeNewswire Inc

Apr 1, 2021

06:48AM EDT HC Wainwright & Co. Maintains Buy on Edap TMS, Raises Price Target to $12 Benzinga

Mar 31, 2021

07:41AM EDT The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO Benzinga

Mar 30, 2021

05:13PM EDT Recap: Edap TMS Q4 Earnings Benzinga

04:36PM EDT EDAP Q4 EPS 0.03 vs (0.03) In Same Qtr. Last Year, Sales $18.3M vs $13.3M In Same Qtr. Last Year Benzinga

04:35PM EDT EDAP Reports Fourth Quarter 2020 Results and Provides Operational GlobeNewswire Inc

08:06AM EDT The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings Benzinga

04:04AM EDT Earnings Scheduled For March 30, 2021 Benzinga

Mar 29, 2021

10:05AM EDT A Preview Of Edap TMS's Earnings Benzinga

Mar 27, 2021

01:01PM EDT The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week Benzinga

Mar 23, 2021

08:00AM EDT Company to host conference call and webcast on Wednesday, March 31 at 8:30 am EDT GlobeNewswire Inc

Mar 3, 2021

08:00AM EST EDAP Selects Leading Reimbursement Consultancies MTP and Argenta GlobeNewswire Inc

Feb 10, 2021

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

Jan 26, 2021

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 22, 2021

07:22AM EST The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa Benzinga

Jan 21, 2021

08:06AM EST 10 Biggest Price Target Changes For Thursday Benzinga

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

06:07AM EST HC Wainwright & Co. Maintains Buy on Edap TMS, Raises Price Target to $10 Benzinga

Jan 20, 2021

08:04AM EST EDAP Sees Q4 2020 Revs. 15.3M Vs Benzinga

08:00AM EST EDAP Announces Record Preliminary Unaudited Fourth Quarter 2020 GlobeNewswire Inc

Jan 19, 2021

08:00AM EST EDAP to Participate in B. Riley Securities Virtual Oncology GlobeNewswire Inc

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 14, 2021

08:16AM EST EDAP Announces 24 Month Interim Results Of French Urology Association Sponsored Clinical Study comparing HIFU To Radical Prostate Surgery Benzinga

08:00AM EST -- Results on 3,329 patients demonstrate significant difference in efficacy in favor of HIFU versus Radical Prostatectomy (RP) -- HIFU treatment also resulted in meaningful benefits in both urinary and erectile function versus RP showing superior quality of life preservation capability GlobeNewswire Inc

07:57AM EST The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates Benzinga

Jan 13, 2021

07:25AM EST The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations Benzinga

Jan 12, 2021

08:16AM EST The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga

Jan 6, 2021

08:12AM EST EDAP Chair, CEO Sends Letter To Shareholders: Recaps 2020 Progress, Previews Expected 2021 Milestones Benzinga

08:00AM EST EDAP Issues Letter to Shareholders GlobeNewswire Inc

Jan 5, 2021

08:00AM EST EDAP to Participate in the LifeSci Partners 10th Annual Healthcare GlobeNewswire Inc

Dec 30, 2020

08:09AM EST EDAP Announces End Of The year Focal One Sales Benzinga

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 9, 2020

08:00AM EST EDAP Announces Final U.S. 2021 Reimbursement Rules for High GlobeNewswire Inc

Nov 20, 2020

06:32AM EST HC Wainwright & Co. Maintains Buy on Edap TMS, Raises Price Target to $6 Benzinga

Nov 18, 2020

05:00PM EST Edap TMS: Q3 Earnings Insights Benzinga

04:36PM EST Edap TMS Q3 EPS $(0.04) Misses $(0.02) Estimate, Sales $11.20M Beat $9.29M Estimate Benzinga

04:35PM EST EDAP Reports Third Quarter 2020 Results and Provides Operational GlobeNewswire Inc

07:30AM EST The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted Benzinga

Nov 17, 2020

10:12AM EST Earnings Outlook For Edap TMS Benzinga

08:09AM EST EDAP Reports Exclusive Distribution Deal With AB Medica, No Terms Disclosed Benzinga

08:00AM EST -- Partnership further extends the availability of EDAPs High Intensity Focused Ultrasound (HIFU) technology to one of the largest markets in Europe GlobeNewswire Inc

Nov 10, 2020

08:47AM EST LYON, France,November 10, 2020--EDAP TMS SA(Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the Jefferies Virtual London Healthcare Conference, which is being heldNovember 17-19, 2020. GlobeNewswire Inc

Nov 9, 2020

08:50AM EST Company to host conference call and webcast on Thursday, November 19 at 8:30 am EDT GlobeNewswire Inc

Sep 15, 2020

08:00AM EDT EDAP Hosting Key Opinion Leader Call on Focal One and GlobeNewswire Inc

Sep 9, 2020

08:00AM EDT LYON, France, September 9, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the HC Wainwright Virtual 22nd Annual Global Investment Conference, which is being held September 14-15, 2020. GlobeNewswire Inc

Sep 3, 2020

08:02AM EDT EDAP Announces First Patients Treated in Phase 2 Study of Focal One for the Treatment of Deep Invasive Endometriosis Benzinga

08:00AM EDT EDAP Announces First Patients Treated in Phase 2 Study of Focal GlobeNewswire Inc

Aug 26, 2020

04:36PM EDT Edap TMS Q2 EPS $(0.01) Beats $(0.08) Estimate, Sales $10.30M Beat $6.72M Estimate Benzinga

04:35PM EDT EDAP Reports Second Quarter 2020 Results and Provides Operational GlobeNewswire Inc

04:07AM EDT Earnings Scheduled For August 26, 2020 Benzinga

Aug 25, 2020

08:10AM EDT EDAP Announces Approval For Phase II Study Evaluating High Intensity Focused Ultrasound (HIFU) For Deep Invasive Endometriosis Benzinga

08:00AM EDT -- Multicenter study to commence in September in France -- Reinforces companys recent shift in strategic focus toward development of additional high-value HIFU tissue ablation indications GlobeNewswire Inc

Aug 19, 2020

08:00AM EDT Company to host conference call and webcast on Thursday, August 27 at 8:30 am EDT GlobeNewswire Inc

Aug 18, 2020

08:29AM EDT EDAP Announces Two Publications Highlighting Favorable HIFU Focal Therapy Outcomes In Journal Of Urology Benzinga

08:00AM EDT EDAP Announces Two Publications Highlighting Favorable HIFU Focal GlobeNewswire Inc

Jul 15, 2020

08:07AM EDT -- Company completes four Focal One sales, including three bundled sales that combine Focal One with Exact Imagings ExactVu micro ultrasound imaging solution -- Company recorded an additional three stand-alone ExactVu purchase orders at major centers GlobeNewswire Inc

Share